Metraipolis › archive › dc_69e7fe9bdb49

Approval delays in multi-country COVID-19 trials: the case of COPCOV and the risk of therapeutic inertia — Europe PMC PMID:41402852

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41402852
DOI
10.1186/s13063-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-10-15T15:55:18.522Z
SHA-256 of the archived text
94f97f694733033d669b1d1c2f92d15213b0b735dd09aa40101d05f20dc5d426
Stable URL of this page
https://metraipolis.com/documento/dc_69e7fe9bdb49

How to cite

Approval delays in multi-country COVID-19 trials: the case of COPCOV and the risk of therapeutic inertia — Europe PMC PMID:41402852 — Europe PMC (en), https://europepmc.org/article/MED/41402852 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69e7fe9bdb49 (Metraipolis archive dc_69e7fe9bdb49, sha256 94f97f694733033d669b1d1c2f92d15213b0b735dd09aa40101d05f20dc5d426)
BibTeX
@misc{dc69e7fe9bdb49,
  title = {Approval delays in multi-country COVID-19 trials: the case of COPCOV and the risk of therapeutic inertia — Europe PMC PMID:41402852},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41402852},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69e7fe9bdb49; sha256 94f97f694733033d669b1d1c2f92d15213b0b735dd09aa40101d05f20dc5d426},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41402852. Agents can read the archived copy with the MCP tool read_document.